
Please try another search
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. On May 27, 2025, the voluntary petition of Biora Therapeutics, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on December 27, 2024.
Name | Age | Since | Title |
---|---|---|---|
Brian L. Kotzin | 74 | 2019 | Independent Director |
Bruce E. Sands | - | 2021 | Chairman of Inflammatory Bowel Disease Clinical Advisory Board |
Jill Ann Howe | 47 | 2021 | Independent Director |
Jeffrey Donald Alter | 60 | 2019 | Independent Chairman |
Aditya P. Mohanty | 56 | 2021 | CEO & Director |
Lynne M. Powell | 57 | 2019 | Independent Director |
Severine Vermeire | - | 2021 | Member of Inflammatory Bowel Disease Clinical Advisory Board |
Brian Gordon Feagan | - | - | Member of Inflammatory Bowel Disease Clinical Advisory Board |
Geert D’Haens | - | 2021 | Member of Inflammatory Bowel Disease Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review